[{"address1": "101 Lindenwood Drive", "address2": "Suite 225", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "484 875 3192", "website": "https://www.annovisbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405, which is in Phase 2 and Phase 3 efficacy studies, an intravenous drug for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials, an orally administered drug to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Malvern, Pennsylvania.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Maria L. Maccecchini Ph.D.", "age": 73, "title": "Founder, CEO, President & Executive Director", "yearBorn": 1951, "fiscalYear": 2023, "totalPay": 681200, "exercisedValue": 0, "unexercisedValue": 5637696}, {"maxAge": 1, "name": "Dr. Cheng  Fang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eve M. Damiano M.S., RAC", "title": "Senior Vice President of Regulatory Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa  Gaines", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Blake  Jensen", "title": "Head of Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hilda  Maibach", "title": "Senior Vice President of Statistics", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.85, "open": 1.7, "dayLow": 1.63, "dayHigh": 1.7326, "regularMarketPreviousClose": 1.85, "regularMarketOpen": 1.7, "regularMarketDayLow": 1.63, "regularMarketDayHigh": 1.7326, "payoutRatio": 0.0, "beta": 1.65, "forwardPE": -0.9116022, "volume": 406054, "regularMarketVolume": 406054, "averageVolume": 503370, "averageVolume10days": 284800, "averageDailyVolume10Day": 284800, "bid": 1.64, "ask": 1.66, "bidSize": 11, "askSize": 9, "marketCap": 32152230, "fiftyTwoWeekLow": 1.53, "fiftyTwoWeekHigh": 20.0, "fiftyDayAverage": 2.7378, "twoHundredDayAverage": 6.60805, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 21600366, "profitMargins": 0.0, "floatShares": 15671217, "sharesOutstanding": 19486200, "sharesShort": 1879232, "sharesShortPriorMonth": 1443813, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0964, "heldPercentInsiders": 0.14446001, "heldPercentInstitutions": 0.13247, "shortRatio": 4.34, "shortPercentOfFloat": 0.11270001, "impliedSharesOutstanding": 20750200, "bookValue": 0.658, "priceToBook": 2.5075989, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -24590376, "trailingEps": -2.31, "forwardEps": -1.81, "52WeekChange": -0.86204016, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 1.65, "targetHighPrice": 72.0, "targetLowPrice": 8.0, "targetMeanPrice": 31.2, "targetMedianPrice": 26.0, "recommendationMean": 1.85714, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 10551916, "totalCashPerShare": 0.542, "totalDebt": 0, "quickRatio": 2.719, "currentRatio": 3.588, "returnOnAssets": -1.38265, "returnOnEquity": -31.59092, "freeCashflow": -12165856, "operatingCashflow": -21894604, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANVS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Annovis Bio, Inc.", "longName": "Annovis Bio, Inc.", "regularMarketChangePercent": -10.8108, "regularMarketPrice": 1.65, "postMarketChangePercent": 9.696967, "postMarketPrice": 1.81, "postMarketChange": 0.15999997, "regularMarketChange": -0.2, "regularMarketDayRange": "1.63 - 1.7326", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 503370, "fiftyTwoWeekLowChange": 0.120000005, "fiftyTwoWeekLowChangePercent": 0.078431375, "fiftyTwoWeekRange": "1.53 - 20.0", "fiftyTwoWeekHighChange": -18.35, "fiftyTwoWeekHighChangePercent": -0.9175, "fiftyTwoWeekChangePercent": -86.20402, "earningsTimestamp": 1742591130, "earningsTimestampStart": 1746734400, "earningsTimestampEnd": 1747080000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.31, "epsForward": -1.81, "epsCurrentYear": -0.78, "priceEpsCurrentYear": -2.1153846, "fiftyDayAverageChange": -1.0877999, "fiftyDayAverageChangePercent": -0.3973263, "twoHundredDayAverageChange": -4.95805, "twoHundredDayAverageChangePercent": -0.7503045, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.9 - Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1743200642, "regularMarketTime": 1743192002, "exchange": "NYQ", "messageBoardId": "finmb_622711087", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1580308200000, "displayName": "Annovis Bio", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]